Fny Investment Advisers, LLC Neoleukin Therapeutics, Inc. Put Options Transaction History

Fny Investment Advisers, LLC

  • $194 Million
  • Q4 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2020

Apr 09, 2020
SELL
$6.12 - $13.64 $153 - $341
-25 Closed
0 $0
Q4 2019

Jan 10, 2020
BUY
$2.65 - $12.72 $66 - $318
25 New
25 $0

Others Institutions Holding NLTX

# of Institutions
1
Shares Held
199K
Call Options Held
0
Put Options Held
0
View Full List

About Neoleukin Therapeutics, Inc.

NLTX Quotes by TradingView
  • Ticker NLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,579,900
  • Description
  • Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...
More about NLTX
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email